- Home
- NTRB vs DYAI Comparison
NTRB vs DYAI Comparison
Compare NTRB & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTRB | DYAI |
|---|---|---|
| Founded | 2016 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.0M | 32.5M |
| IPO Year | 2019 | 2003 |
Fundamental Metrics
Financial Performance| Metric | NTRB | DYAI |
|---|---|---|
| Price | $3.14 | $0.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.00 |
| AVG Volume (30 Days) | 8.1K | ★ 217.3K |
| Earning Date | 05-29-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | $2,036,651.00 | ★ $3,090,345.00 |
| Revenue This Year | $30.17 | $122.79 |
| Revenue Next Year | $3,394.36 | $100.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.80 | $0.65 |
| 52 Week High | $8.63 | $1.60 |
Technical Indicators
Market Signals| Indicator | NTRB | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 57.64 | 46.34 |
| Support Level | $2.91 | $0.76 |
| Resistance Level | $3.16 | $1.17 |
| Average True Range (ATR) | 0.11 | 0.11 |
| MACD | 0.04 | -0.03 |
| Stochastic Oscillator | 77.83 | 12.50 |
Price Performance
Historical ComparisonAbout NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.